LEVI-04 for Osteoarthritis: The Breakthrough Drug That’s Changing Knee Pain Treatment in 2026
If your knee pain has felt impossible to manage, there is finally real clinical evidence pointing toward a new solution: LEVI-04 for osteoarthritis is a first-in-class NT-3 inhibitor that delivered statistically significant pain relief in Phase II trials, with over 50% of patients achieving at least a 50% reduction in pain scores by week 17….
